BEQALZI
Live / Applied — First extension granted (statement of use) (as of 27 Jan 2026)
What this means for you
Not registered yet, but its 30 Apr 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99162966
- Mark type
- Stylized text
- Filed
- 30 Apr 2025
- Published for opposition
- 01 Jul 2025
- Attorney of record
- Kristen S. Ruisi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases and infectious diseases
Owner
- BEONE MEDICINES I GMBH, BASEL, CH
- BeiGene Switzerland GmbH, Basel, CH
- BeiGene Switzerland GmbH, Basel, CH
Prosecution history
- 28 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jan 2026 — SOU EXTENSION 1 GRANTED
- 27 Jan 2026 — SOU EXTENSION 1 FILED
- 27 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 26 Aug 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Jul 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 09 Jul 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 01 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Jul 2025 — PUBLISHED FOR OPPOSITION
- 25 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Jun 2025 — POST PUBLICATION AMENDMENT - ENTERED
- 12 Jun 2025 — ASSIGNED TO LIE
- 04 Jun 2025 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 31 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 May 2025 — ASSIGNED TO EXAMINER